MedPath

Effects of Anesthetic agents (propofol vs. remimazolam) on recovery outcomes in patients undergoing arrhythmia catheter ablatio

Not Applicable
Completed
Conditions
Diseases of the circulatory system
Registration Number
KCT0007132
Lead Sponsor
Samsung Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
100
Inclusion Criteria

1) ASA class I-IV adult (19-70 years of age)
2) Undergoing elective cathter ablation procedure for atrial fibrillation/flutter under general anesthesia

Exclusion Criteria

1) History of hypersensitivity to benzodiazepines or propofol
2) Moderate liver disease (Child-Pugh B/C)
3) Diagnosed with metabolic disease
4) Pregnant or breast-feeding
5) Acute glaucoma
6) Galactose intolerance, lactose intolerance, or glucose-galactose absorption disorder
7) Severe hypersensitivity to Dextran 40

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Factors related to emergence (Time to obey commands)
Secondary Outcome Measures
NameTimeMethod
Hemodynamic stability;Time variables related to emergence (Times to BIS over 80, LMA removal);Modified Aldrete Scores in PACU;Side effects related to drug use
© Copyright 2025. All Rights Reserved by MedPath